In vivo antitumor activity of 5-hydroxy-6-[N,N-bis(2-chloroethyl)aminomethyl]naphthalene-1,8- carbolactone.
Riondel
J
J
Laboratoire de Physiologie et Pharmacologie I, Faculté de Pharmacie de Grenoble, France.
Boitard
M
M
Bouaziz
Z
Z
Fillion
H
H
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003537:Cystadenoma / Q000188:drug therapy; D005260:Female; D006801:Humans; D007939:Leukemia L1210 / Q000188:drug therapy; D008297:Male; D051379:Mice; D009284:Naphthols / Q000494:pharmacology*; D009368:Neoplasm Transplantation; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000970:Antineoplastic Agents; D009284:Naphthols; D009588:Nitrogen Mustard Compounds; C075115:5-hydroxy-6-(N,N-bis(2-chloroethyl)aminomethyl)naphthalene-1,8-carbolactone